- (1) As used in this section, unless the context otherwise requires, continuous glucose monitor means an instrument or a device designed for the purpose of aiding in the treatment of diabetes by measuring glucose levels on demand or at set intervals through a small electronic sensor that slightly penetrates an individual's skin when applied and that is designed to remain in place and active for at least seven days.
(2)
- (a) Beginning November 1, 2025, the state department shall provide coverage for a continuous glucose monitor and related supplies to members under the medicaid medical and pharmacy benefit.
- (b) Coverage criteria must align with the current glucose monitor local coverage determination standards issued by the centers for medicare and medicaid that are used to determine coverage for medicare-eligible individuals, including individuals with gestational diabetes not being treated with insulin.
- (3) Coverage pursuant to this section includes the cost of any necessary repairs or replacement parts for the continuous glucose monitor.
- (4) The state department may seek any federal authorization necessary to implement this section.
- (5) The state department is authorized to receive and expend gifts, grants, and donations from individuals, private organizations, foundations, or any governmental unit; except that no gift, grant, or donation may be accepted by the state department if it is subject to a condition that is inconsistent with this section or any other law of this state.
Source: L. 2024: Entire section added, (SB 24-168), ch. 281, p. 1878, § 3, effective August 7.
Cross references: For the legislative declaration in SB 24-168, see section 1 of chapter 281, Session Laws of Colorado 2024.